Tyler O. Kirby

Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation☆

James L. Wilder, Edward J. Pavlik, J. Michael Straughn et al. · Gynecologic Oncology · 2003 · 76 citations

Serum Ca-125, Epithelial Ovarian Cancer, Medicine +7

A Novel <b> <i>Ex vivo</i> </b> Model System for Evaluation of Conditionally Replicative Adenoviruses Therapeutic Efficacy and Toxicity

Tyler O. Kirby, Ángel Rivera Novoa, Daniel Rein et al. · Clinical Cancer Research · 2004 · 70 citations

A Pilot Study of Ovarian Cancer Chemoprevention Using Medroxyprogesterone Acetate in an Avian Model of Spontaneous Ovarian Carcinogenesis

Mack N. Barnes, Wallace D. Berry, J. Michael Straughn et al. · Gynecologic Oncology · 2002 · 62 citations

Hormonal Contraceptive, Chemoprevention Strategy, Medicine +11

Bowel Resection at the Time of Primary Debulking for Epithelial Ovarian Carcinoma: Outcomes in Patients Treated with Platinum and Taxane-Based Chemotherapy

Jacob M. Estes, Charles A. Leath, Michael Straughn et al. · Journal of the American College of Surgeons · 2006 · 58 citations

A Prospective Evaluation of "See and Treat" in Women with HSIL Pap Smear Results: Is This an Appropriate Strategy?

T. Michael Numnum, Tyler O. Kirby, Charles A. Leath et al. · Journal of Lower Genital Tract Disease · 2005 · 56 citations